July 27, 2022
Accelerating Drug Discovery with Human-Relevant 3D Engineered Muscle Tissue Analysis SEATTLE, WA — Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, today announced the commercial launch of the Mantarray™ platform for human-relevant 3D heart and skeletal engineered muscle tissue (EMT) contractility analysis. Curi’s Mantarray platform enables the discovery of new therapeutics [...]
July 27, 2022
DRAGEN™ v4.0 brings greater accuracy, comprehensiveness, and efficiency to genomic analysis than ever before, unlocking the full potential of genomics to improve human health SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the release of Illumina DRAGEN™ v4.0, its most accurate and comprehensive secondary analysis platform. [...]
July 27, 2022
Using Berkeley Lights' high-throughput, functional screening service, Aanika BioSciences will now rapidly commercialize the propriety peptide to help improve and protect global food system EMERYVILLE, Calif. -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Aanika Biosciences, a growing biotech start-up using edible microbial tags to improve food safety, today announced that [...]
AlpHa Measurement Solutions Acquires Fluorometrics Instruments
July 26, 2022
Houston, TX – AlpHa Measurement Solutions LLC (AlpHa), a leader in the liquid sensing technology segment of the test and measurement space, yesterday announced the acquisition of Fluorometrics Instruments LLC (FMI), a designer and manufacturer of optical chemical sensor systems and fiber-optic chemical sensors. Terms of the deal were not disclosed. With a record of strong [...]
July 26, 2022
Brings differentiated miniaturization technology, scientific and engineering expertise, and enhanced ease-of-use capabilities to SomaLogic’s platform while expanding footprint to San Diego, CA BOULDER, Colo. and SAN DIEGO -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into an agreement to acquire Palamedrix, Inc., an innovator in DNA nanotechnology. Palamedrix [...]
July 26, 2022
News Summary: Waters is providing both technology and expertise to help advance the science of plant-based proteins and tackle problems of climate change and food security Waters joins the Plant Protein Innovation Center at the University of Minnesota to collaborate with more than 50 leading researchers and industry partners Researchers will use Waters’ ACQUITY Premier [...]
Eppendorf: climate-neutral by 2028
July 26, 2022
Comprehensive climate strategy with the goal of climate neutrality by 2028 Successful start of implementation at all locations worldwide Results of initial measures already visible Hamburg – The globally positioned Eppendorf Group, a life science specialist, is picking up speed when it comes to climate protection. The company is reducing its CO2 emissions and will [...]
Synthego Expands Capabilities of Halo Platform with Next-Generation Manufacturing Facility
July 26, 2022
New Facility Designed to Accelerate Growth of CRISPR-mediated Cell and Gene Therapies with Transformative Increase in Manufacturing Capacity REDWOOD CITY, Calif. - Synthego, the genome engineering company, announced today that the company has broken ground on a 20,000-square-foot manufacturing facility designed to accelerate translational and clinical research development timelines for cell and gene therapies to as [...]
July 26, 2022
EMERYVILLE, Calif. -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Otsuka Pharmaceuticals, a leading pharmaceutical company, has implemented the use of the Berkeley Lights Beacon® system for antibody discovery, as well as cell and gene therapy and cell line development research. Since acquiring the Beacon Platform in October 2021, Otsuka Pharmaceutical scientists have [...]
lino Biotech Expands Board of Directors
July 26, 2022
Dr. Matthias Essenpreis, Chief Technology Officer at Roche Diagnostics, complements the team of lino Biotech´s board members ZURICH -- lino Biotech AG, a spin-out from Roche Diagnostics that has developed a reagent-free method for measuring molecular interactions in living cells or crude biological samples, welcomes Dr. Matthias Essenpreis as its new board member. With his [...]

